Dash Bio
Boston
About Dash Bio
Dash Bio is a modern automated platform. It is redesigning drug development from the ground up, using AI, robotics, and fully integrated software to fundamentally change the way medications are brought to market.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $17.5M
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: dash.bio
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Robotics, Software
Social Profiles
Canonical: https://fsome.com/organization/dash-bio-44845 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.